Metabolic plasticity increases evolvability and drives persistence to PARP inhibitor in ovarian cancer
Adriana Del Pino Herrera, Joon-Hyun Song, Karla Torres‐Arciga, Susoma Halder, Kadin El Bakkouri, Jowana Obeid, William M. Burke, Mehdi Damaghi, Meghan C. Ferrall-Fairbanks
Ovarian cancer cells exploit metabolic plasticity to increase their evolvability to persist PARP inhibitor treatment.
bioRxiv · Oct 8, 2025 · PreprintCancer Biology